Incyte’s JAK inhibitor scores phase 3 vitiligo wins but can’t quite shake off Rinvoq
Incyte’s JAK inhibitor scores phase 3 vitiligo wins but can’t quite shake off Rinvoq
Contenu indisponible. Consultez la source originale.
Incyte’s JAK inhibitor scores phase 3 vitiligo wins but can’t quite shake off Rinvoq
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.